Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Long-Term Debt Repayments (2016 - 2025)

Haemonetics has reported Long-Term Debt Repayments over the past 16 years, most recently at $1.6 million for Q4 2025.

  • Quarterly results put Long-Term Debt Repayments at $1.6 million for Q4 2025, changed 0.06% from a year ago — trailing twelve months through Dec 2025 was $51.6 million (up 235.37% YoY), and the annual figure for FY2025 was $50.0 million, up 308.16%.
  • Long-Term Debt Repayments for Q4 2025 was $1.6 million at Haemonetics, roughly flat from $1.6 million in the prior quarter.
  • Over the last five years, Long-Term Debt Repayments for HAE hit a ceiling of $50.0 million in Q2 2024 and a floor of -$48.4 million in Q3 2024.
  • Median Long-Term Debt Repayments over the past 5 years was $1.8 million (2022), compared with a mean of $4.0 million.
  • Peak annual rise in Long-Term Debt Repayments hit 2757.14% in 2024, while the deepest fall reached 1483.91% in 2024.
  • Haemonetics' Long-Term Debt Repayments stood at $4.4 million in 2021, then plummeted by 60.0% to $1.8 million in 2022, then plummeted by 400.0% to -$5.2 million in 2023, then skyrocketed by 129.75% to $1.6 million in 2024, then grew by 0.06% to $1.6 million in 2025.
  • The last three reported values for Long-Term Debt Repayments were $1.6 million (Q4 2025), $1.6 million (Q3 2025), and $1.6 million (Q2 2025) per Business Quant data.